LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular disease

Preventive Cardiology Congress Athens 2024

US Study Publication in the American Journal of Preventive Cardiology

Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode
as method to target treatment

Lipid inCode® offers greater diagnostic information for hypercholesterolemia sufferers over current NHS standard

Commencement of regulatory pathway for U.S. market approval